From Cure to Crisis: A Case of Severe Hypoxic Respiratory Failure Due to Daptomycin-Associated Eosinophilic Pneumonitis

Daptomycin is a cyclic lipopeptide antibiotic that commonly treats Gram-positive infections. Most frequently prescribed for osteoarticular infections.1 Daptomycin is associated with numerous side effects, including myopathy, rhabdomyolysis, eosinophilic pneumonia, and anaphylactic hypersensitivity reactions.1 Daptomycin-induced eosinophilic pneumonitis (DIEP) is a rare but potentially life-threatening adverse effect associated with prolonged use.2 There are several established criteria for diagnosing this medical condition. However, the variation in its clinical presentation, coupled with the favorable outcomes of early diagnosis and the severe consequences of delayed diagnosis, emphasizes the need for further discussions. This case highlights the importance of monitoring patients on prolonged daptomycin therapy for this serious complication. Furthermore, it emphasizes the value and limitations of standardized scoring tools as clinical aids in decision-making, early diagnosis, and timely treatment.